Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Adrian Leonard Smith is active.

Publication


Featured researches published by Adrian Leonard Smith.


Bioorganic & Medicinal Chemistry Letters | 2000

2-Aryl tryptamines: selective high-affinity antagonists for the h5-HT2A receptor

Graeme Irvine Stevenson; Adrian Leonard Smith; Stephen John Lewis; Stephen G Michie; Joseph George Neduvelil; Smita Patel; Rosemarie Marwood; Shil Patel; José L. Castro

A series of 2-aryl tryptamines have been identified as high-affinity h5-HT2A antagonists. Structure-activity relationship studies have shown that h5-HT2A affinity can be attained via modifications to the tryptamine side chain and that selectivity over h5-HT2C and hD2 receptors can be controlled by suitable C-2 aryl groups.


Tetrahedron Letters | 1998

Traceless solid phase synthesis of 2,3-disubstituted indoles

Adrian Leonard Smith; Graeme Irvine Stevenson; Christopher John Swain; JoséL. Castro

Abstract An efficient method for the traceless solid phase synthesis of 2,3-disubstituted indoles using a THP linker and a Pd(0)-mediated annulation of 2-iodoaniline and acetylenes is reported.


Bioorganic & Medicinal Chemistry Letters | 1996

An Efficient Solid‐Phase Synthetic Route to 1,3‐Disubstituted 2,4(1H,3H)‐Quinazolinediones Suitable for Combinatorial Synthesis

Adrian Leonard Smith; Christopher G. Thomson; Paul D. Leeson

Abstract Novel, efficient solid phase chemistry has been developed for the synthesis of 1,3-disubstituted quinazolinediones. Anthranilic acids are linked to a chloroformate resin through the nitrogen, amines are coupled to the free carboxylic acid, and thermal cyclization leads to heterocycle formation and concommitant resin release resulting in traceless linkage.


Bioorganic & Medicinal Chemistry Letters | 2000

Solid-phase synthesis of 2,3-disubstituted indoles: discovery of a novel, high-affinity, selective h5-HT2A antagonist.

Adrian Leonard Smith; Graeme Irvine Stevenson; Stephen John Lewis; Smita Patel; Jose L. Castro

The application of a novel solid-phase synthesis of 2,3-disubstituted indoles utilizing a carbamate indole linker is described resulting in the identification of the novel, high-affinity, selective h5-HT2A antagonist 19.


Nature | 2000

Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1

Yueming Li; Min Xu; Ming-Tain Lai; Qian Huang; José L. Castro; Jillian DiMuzio-Mower; Timothy Harrison; Colin Lellis; Alan Nadin; Joseph George Neduvelil; R. Bruce Register; Mohinder K. Sardana; Mark S. Shearman; Adrian Leonard Smith; Xiao-Ping Shi; Kuo-Chang Yin; Jules A. Shafer; Stephen J. Gardell


Biochemistry | 2000

L-685,458, an Aspartyl Protease Transition State Mimic, Is a Potent Inhibitor of Amyloid β-Protein Precursor γ-Secretase Activity

Mark S. Shearman; Dirk Beher; Earl E. Clarke; Huw D. Lewis; Peter Hunt; Alan Nadin; Adrian Leonard Smith; and Graeme Stevenson; José L. Castro


Bioorganic & Medicinal Chemistry Letters | 2005

A novel series of potent γ-secretase inhibitors based on a benzobicyclo[4.2.1]nonane core

Stephen John Lewis; Adrian Leonard Smith; Joseph George Neduvelil; Graeme Irvine Stevenson; Matthew John Lindon; A. Brian Jones; Mark S. Shearman; Dirk Beher; Earl E. Clarke; Jonathan D. Best; James Peachey; Timothy Harrison; J. Luis Castro


Archive | 2001

Sulphonamido-substituted bridged bicycloalkyl derivatives

Patrice Charles Belanger; Ian Collins; Joanne Claire Hannam; Stephen John Lewis; Andrew Madin; Iver Edward Giles Mc; Alan Nadin; Joseph George Neduvelil; Mark S. Shearman; Adrian Leonard Smith; Timothy Jason Sparey; Graeme Irvine Stevenson; Martin Richard Teall


Archive | 1994

Antipsychotic indazole derivatives

Raymond Baker; Janusz Jozef Kulagowski; Paul D. Leeson; Adrian Leonard Smith


Archive | 1997

Chemical synthesis of 1,3-disubstituted quinazolinediones

Adrian Leonard Smith

Researchain Logo
Decentralizing Knowledge